{"retracted":false,"update":{"timestamp":1437436800000,"doi":"10.1371/journal.pone.0134190","type":"correction"},"doi":"10.1371/journal.pone.0059414","journal":"PLOS ONE","publisher":"Public Library of Science (PLoS)","title":"Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks"}
